RxDoctor Payments Data

Thomas Grimm, MD

Family Medicine · Cincinnati, OHNPI 1659363687

Payments from drug & device makers

$5,031in general payments, 2019–2025

Across 342 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$753
  • Novo Nordisk$676
  • Pfizer$676
  • GSK$272
  • Merck$247
  • Lilly USA, LLC$184
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,031100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,031 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$66,851
Medicare patients
245
Services billed
848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin50$79,401
EliquisApixaban61$49,791
SynjardyEmpagliflozin/Metformin Hcl22$30,688
JanuviaSitagliptin Phosphate37$29,446
XareltoRivaroxaban21$28,378
TrulicityDulaglutide20$27,873
OzempicSemaglutide13$17,721
MounjaroTirzepatide15$15,402
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,284
Soliqua 100-33Insulin Glargine/Lixisenatide11$8,116
SymbicortBudesonide/Formoterol Fumarate16$5,700
Clorazepate Dipotassium38$3,612
Atorvastatin Calcium417$3,304
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,677
Metoprolol Succinate132$2,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy$148$110,08972 claims
PfizerEliquis$676$49,79161 claims
Lilly USA, LLCTrulicity, Mounjaro$184$43,27635 claims
MerckJanuvia$247$29,44637 claims
Johnson & JohnsonXarelto$157$28,37821 claims
Novo NordiskOzempic$676$17,72113 claims
GSKTrelegy Ellipta$272$13,28413 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$37$8,11611 claims
AstraZenecaSymbicort$153$5,70016 claims
AbbVieSynthroid$753$1,58847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →